Bigul

NOVARTIS INDIA LTD. - 500672 - Record Date For Payment Of Dividend For The Year Ended March 31, 2020 As Recommended By The Board, If Approved At The Annual General Meeting.

Record date and Dividend payment i.Pursuant to the provisions of Section 91 of the Act, the Register of Members and Share Transfer Books will remain closed on all days from Friday, July 31, 2020 to Friday, August 07, 2020, both days inclusive. ii.Payment of dividend for the year ended March 31, 2020 as recommended by the Board, if approved at the AGM, will be payable within thirty days from the date of its declaration to the shareholders whose names appear in the Company's Register of Members as on 7th August 2020 and to those whose names will appear as Beneficial Owners as on record date i.e. July 30, 2020 as per the details to be furnished by the Depositories. The above is for your information and record.
08-07-2020
Bigul

NOVARTIS INDIA LTD. - 500672 - Announcement under Regulation 30 (LODR)-Newspaper Publication

The Company has made notice in the 'Financial Express' and 'Loksatta' on July 8, 2020, for attention of its Shareholders in respect of information regarding the Annual General Meeting of the Members scheduled to be held on August 7, 2020 through VC/ OAVM. Enclosed herewith the copies of the newspaper notices.
08-07-2020

Novartis to pay $678 million to settle doctor-bribe claims

Novartis paid exorbitant speaker fees to doctors who gave no meaningful presentations, and provided expensive meals and alcohol to doctor attendees and their guests,' federal prosecutors say
02-07-2020
Bigul

NOVARTIS INDIA LTD. - 500672 - Closure of Trading Window

Dear Sir/ Madam, Pursuant to the Company''s Code of Conduct to regulate, monitor and report share trading by Insiders ["the Code"], the trading window for dealing in securities of the Company shall remain closed from Wednesday, July 1, 2020. The Trading Window shall open 48 (forty eight) hours after the Unaudited Financial results for the quarter ended June 30, 2020 are made public. The same is being duly communicated to all the Designated Persons under the Code which is available on the Company''s website i.e. www.novartis.in. This is for your information. Thanking You.
30-06-2020
Bigul

NOVARTIS INDIA LTD. - 500672 - Compliances-Reg.24(A)-Annual Secretarial Compliance

Pursuant to Regulation 24A of Securities Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find enclosed the Annual Secretarial Compliance Report of the Company issued by Mr. K. G. Saraf, Practicing Company Secretary for the financial year 2019-20. You are requested to kindly take the above information on record.
24-06-2020
Bigul

NOVARTIS INDIA LTD. - 500672 - Announcement under Regulation 30 (LODR)-Newspaper Publication

Apropos the subject matter quoted above, please find enclosed herewith the copies of the newspaper Notices in 'Financial Express' and 'Navshakti' on June 20, 2020. This is for your information and record.
22-06-2020
Bigul

NOVARTIS INDIA LTD. - 500672 - Fixes Book Closure for Final Dividend & AGM

Novartis India Ltd has informed BSE that the Register of Members & Share Transfer Books of the Company will remain closed from July 31, 2020 to August 07, 2020 (both days inclusive) for the purpose of Payment of Final Dividend & 72nd Annual General Meeting (AGM) of the Company to be held on August 07, 2020.
20-06-2020

Novartis India Q4 net profit declines 65% to Rs 6.78 crore

For the full fiscal 2019-20, the company posted a net profit of Rs 10.08 crore compared to Rs 51.77 crore in the previous financial year, Novartis India said.
19-06-2020
Bigul

NOVARTIS INDIA LTD. - 500672 - Audited Financial Results Of The Company For The Fourth Quarter And Year Ended March 31, 2020;

Kindly note that the Board of Directors of the Company has in its meeting held today i.e. on Friday, June 19, 2020 ("said meeting"), inter alia have approved: 1.Audited Financial Results of the Company for the fourth quarter and year ended March 31, 2020; 2.Recommendation of final dividend of Rs. 10/- per Equity share of Rs. 5/- each for the year ended March 31, 2020, subject to approval of the shareholders of the Company. Details of the same along with the other matters approved in the Board Meeting is enclosed herewith. This is for your information and records.
19-06-2020
Bigul

NOVARTIS INDIA LTD. - 500672 - Appointment Of Mr. Sanker Parameswaran As An Additional (Independent And Non- Executive) Director Of Novartis India Limited ('The Company')

Kindly note that, pursuant to the recommendation of the Nomination and Remuneration Committee, Board of Directors of the Company at its meeting held today i.e. on Friday, June 19, 2020, approved the appointment of Mr. Sanker Parameswaran as an Additional (Independent & Non-Executive) Director of the Company for a term of five (5) years w.e.f. June 22, 2020. The appointment of Mr. Parameswaran as an Independent Director is subject to the approval of the shareholders at the ensuing Annual General Meeting of the Company. Brief profile of Mr. Parameswaran along with necessary confirmations is enclosed herewith. The above is for your information and records.
19-06-2020
Next Page
Close

Let's Open Free Demat Account